Back to all Programs

Register here

Related Materials

Past event

European Meeting on HIV & Hepatitis 2016

Viral Hepatitis and Liver Disease

HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhD

Viral Hepatitis and Liver Disease

Roadblocks to implementation | Pep Coll, MD

Viral Hepatitis and Liver Disease

Community perspective | Rebekah Webb

Viral Hepatitis and Liver Disease

Session 4 Discussion

Viral Hepatitis and Liver Disease

HIV attachment Inhibitors - Educational lecture in collaboration with ESAR | Thomas Klimkait, MD

Viral Hepatitis and Liver Disease

Maintenance Therapy - What is the scientific/ virological rational | Charles Boucher, MD, PhD

Viral Hepatitis and Liver Disease

Session 5 Discussion

Viral Hepatitis and Liver Disease

PI remain important options for first line | Linos Vandekerckhove, MD, PhD

Viral Hepatitis and Liver Disease

Improving PI drug resistance scores | Jens Verheyen, MD, PhD

Viral Hepatitis and Liver Disease

Session 7 Discussion